Genetics of CYP1A1: Coamplification of Specific Alleles by Polymerase Chain Reaction and Association with Breast Cancer

Timothy R. Rebbeck, Elizabeth A. Rosvold, David J. Duggan, John Zhang, Kenneth H. Buetow

Research output: Contribution to journalArticle

43 Scopus citations

Abstract

CYP1A1 is a gene of the cytochrome P-450 family that has been proposed to be a biomarker of cancer risk. We introduce a polymerase chain reaction-based assay to measure allelic variability in exon 7 of the CYP1A1 gene. This genetic variant is associated with an amino acid change at residue 462 in the aryl hydrocarbon hydroxylase protein product. Previously, measurement of CYP1A1 genotypes at this variant site required two assays, one to detect each allele. By using three primers in a single polymerase chain reaction rather than two primers in each of two polymerase chain reactions, the proposed assay may facilitate population-based study protocols. We estimate the frequency of this polymorphism in a Caucasian population to be 0.03, with an observed heterozygosity of 0.06. We have also confirmed the Mendelian segregation of this polymorphism in four multigeneration Centre d'Etude du Polymorphisme Humain families and have placed this locus in a multilocus linkage map on chromosome 15q. The distribution of this polymorphism was the same in breast cancer cases as in two sets of healthy Controls.

Original languageEnglish (US)
Pages (from-to)511-514
Number of pages4
JournalCancer Epidemiology Biomarkers and Prevention
Volume3
Issue number6
StatePublished - Sep 1 1994
Externally publishedYes

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Fingerprint Dive into the research topics of 'Genetics of CYP1A1: Coamplification of Specific Alleles by Polymerase Chain Reaction and Association with Breast Cancer'. Together they form a unique fingerprint.

  • Cite this